Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
P09668
UPID:
CATH_HUMAN
Alternative names:
-
Alternative UPACC:
P09668; B2RBK0; Q96NY6; Q9BUM7
Background:
Pro-cathepsin H plays a pivotal role in the lysosomal degradation pathway, essential for protein turnover and cellular homeostasis. This enzyme, encoded by the gene with the UniProt accession number P09668, is synthesized as an inactive precursor that is activated in the acidic environment of the lysosome.
Therapeutic significance:
Understanding the role of Pro-cathepsin H could open doors to potential therapeutic strategies. Its critical function in protein degradation positions it as a key target for interventions in diseases where protein accumulation or misfolding is a factor.